Histogenics Corp.

Histogenics Corp.
Stock Exchange NASDAQ Stock Market
EPS
$0.59
Market Cap
$18.89 M
Shares Outstanding
94.6 M
Public Float
52.1 M

Profile

Address
830 Winter Street
Waltham Massachusetts 02451
United States
Employees -
Website http://www.histogenics.com
Updated 07/08/2019
Histogenics Corp. engages in the development, marketing, and commercialization of musculoskeletal medicine. Its regenerative medicine platform combines expertise in cell processing, scaffolding, tissue engineering, bioadhesives, and growth factors to provide solutions that can be utilized individually and in concert to treat musculoskeletal-related conditions. The company was founded on June 28, 2000 and is headquartered in Waltham, MA.

Financials

View All

Adam D. Gridley
President, Chief Executive Officer & Director
Susan B. Washer
Director